In solid-phase minisequencing,a defined point mutation is detected in microtiter plate-immobilized DNA by a single nucleotide primer extension reaction. We have here developed the method into a colorimetricassay and applied it to the detection of the Z mutation of the a1-antitrypsin gene. We used novel nucleoside triphosphates modified with dinitrophenyl (DNP) hapten,permittingdetectionby Allele-specific amplification, oligonucleotide ligation, and allele-specific oligonucleotide hybridization assays are all based on the capability of hybridization to distinguish one base pair (1 bp) mismatch.
Allele-specific amplification, oligonucleotide ligation, and allele-specific oligonucleotide hybridization assays are all based on the capability of hybridization to distinguish one base pair (1 bp) mismatch.
The method we developed for detection of point mutations is based on the specificity of primer extension reaction (10) and has been formatted into a microtiter plate-based diagnostic test (11). In this solid-phase minisequencing method, the point mutation is detected in a microtiter plateimmobilized amplified target by a primer extension reaction, in which one labeled nucleotide is enzymatically incorporated at the site of mutation. For each analyzed sample two minisequencing reactions are performed, one for the normal allele and one for the mutated allele. Unlike the other methods mentioned above, the minisequencing reaction yields quantifiable results.
We describe here a colorimetric minisequencing method for the detection of the Z mutation of the a1-antitrypsin (A1AT) gene. In the test we make use of novel hapten-labeled nucleoside triphosphates, which permits immunoenzymatic detection on microtiter plates.
Deficiency of A]AT is one of the most common hereditary disorders in Caucasians. Most cases involve two mutations, Z and S. The frequency of the Z-allele is 1-2%, that of the S-allele is 2-4% (12) . The Z mutation of the ALAT gene is a G9989 to A tranaversion, which results in Glu 342 to Lys 342 substitution (13) . Homozygosity for the Z mutation leads to pulmonary emphysema, and -10% of the ZZ homozygous individuals develop chronic liver disease.
Diagnosis of A1AT deficiency is based on the measurement of AIAT in plasma, an analysis that is readily available in most hospital laboratories. Suspected cases are then phenotyped by isoelectric focusing, which requires technical skills and is available only in a few laboratories. Genotyping of A1AT-deficient patients has been described in several publications, but the techniques have been neither simple nor standardized (14, 15). The novel technique for genotyping the Z mutation as described here is nonradioactive, rapid, and simple and is suitable for use in a clinical chemistry laboratory.
Materials and Methods
Preparation of DNA samples. Blood samples were obtained from the Laakso and Aurora Hospitals, Helsinki. DNA was extracted from 0.5 mL of EDTA blood accordingto Walsh et al. (16 (DuPont) . After the reaction mixtures were incubated for 15 miii at 55#{176}C, 5 L of Stop solution (United States Biochemical, Cleveland, OH) was added, the samples were boiled for 5 miii, and the samples were loaded onto 10% sequencing gel.
Results

Principle
A 126-bp fragment of exon V of the A1AT gene is amplified with one biotunylated and one unbiotinylated should remain specific, they must be accepted as substrate by the DNA polymerase, and the DNP group must be accessible to detection by the antibody.
To establish this assay, we studied the specificity of primer extension and the acceptability of the newly synthesized DNP-dCTP and DNP-dUTP by DNA polymerase. In this assay the 32P-labeled detection primer ZD was hybridized to the biotinylated minisequencing control oligonucleotides BIO-CM and BIO-C. The prmera were elongated with DNP-dCTP and DNP-dTJTP by using Taq DNA polymerase, and the elongation products were analyzed on a sequencing gel. The highest ratio of specific to nonspecific signal was obtained with 0.5-5 pmol of DNPdCTP or DNP-dUTP per reaction ( Figure 3B ).
Sensitivity and Detection Range
The sensitivity of the colorimetric DNP-minisequencing assay is demonstrated in Figure 4 . The detection limit (ratio of the specific signal to unspecific incorporation 2) when using DNP-dCTP or DNP-dUTP was about 5 x 10#{176} target DNA molecules. The linear detection range was close to two orders of magnitude (5 x 10#{176} to 5 x 1011 target molecules).
Colorimetric vs LuminometricDetection
By using the anti-DNP-allcsiline phosphatase conjugate we could select from a variety of substrates: for detection by colorimetiy, p-nitrophenyl phosphate; by fluorometry, ArFOPHOS'
(JBL Scientific, San Luis Obispo, CA) and 4-methylumbelliferyl phosphate; by iuminometiy, Lumigen. When we compared the sensitivities of colorimetric and luminometric detection, we found the detection limits were similar: 10#{176}-S x 10#{176} molecules of target DNA (Figures 4 and 5) . The dynamic range of the luminometric assay was consistently 2.5 orders of magnitude.
The signal leveled off at target concentrations >1012 molecules because of the limiting quantity of DNP-nudeotide added to the reaction. Furthermore, the microtiter well does not bind more than 5 x 1012 molecules of biotinylated DNA.
Analysis of GenomicDNASamples
Eight clinical samples were amplified and analyzed by the colorimetric minisequencing test for A1AT Z mutation (Table 2) . To interpret the results of the minisequencing assay, we used R, the ratio of the sig- 
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(see Table 1 ).
nals obtained with DNP-dCTP and DNP-dUTP. The R values for the different genotypes were as follows: <0.05 for ZZ homozygote, 0.9-1.3 for MZ heterozygote, and >19 for MM homozygote. Because the clinical material did not contain a homozygous Z sample, we had to obtain the R value for a ZZ homozygote by using the amplification control oligonudeotide. We repeated the minisequencing assay five times, using two MM sampies and two MZ samples. The CV varied between 6% and 14%. The results obtained with the colorimetric minisequencing assay were in all cases in concordance with those of the isoelectric focusing assay (19) used as the standard comparison test. A1AT has another significant mutation in addition to the Z mutation in exon V, i.e., the S mutation, an A to T transversion in exon III leading to the substitutioi of Glu to Val at position 264 (22). This mutation is he next most common after the Z mutation and carriers have A]AT activities 50-60% of normal (12). Diagnosis of SZ compound heterozygutes might be clinically important.
Discussion
Diagnosis of genetic diseases in a
We are currently constructing a colorimetric, microtiter plate-based test for detecting the S mutation of the A1AT gene.
